These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 9666634)

  • 21. Lymphocyte glucocorticoid receptor: predictor of sertraline response in adolescent major depressive disorder (MDD).
    Sallee FR; Nesbitt L; Dougherty D; Hilal R; Nandagopal VS; Sethuraman G
    Psychopharmacol Bull; 1995; 31(2):339-45. PubMed ID: 7491389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats.
    Butler J; Tannian M; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):585-94. PubMed ID: 3222448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased platelet [3H]paroxetine binding sites in suicide attempters.
    Marazziti D; Dell'Osso L; Rossi A; Masala I; Baroni S; Armani A; Giannaccini G; Di Nasso E; Lucacchini A; Cassano GB
    Psychiatry Res; 2001 Sep; 103(2-3):125-31. PubMed ID: 11549401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antidepressants on the cytochrome P450 system.
    Preskorn SH
    Am J Psychiatry; 1996 Dec; 153(12):1655-7. PubMed ID: 8942473
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet serotonin transporter in drug-naive migrainous children and adolescents.
    Weizman A; Fluhr H; Weitz R; Kehat R; Inbar D; Cohen A; Mester R; Rehavi M
    Biol Psychiatry; 1994 Apr; 35(7):452-6. PubMed ID: 8018796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet paroxetine binding in depressed and nondepressed chronic pain patients.
    Jensen NH; Lauritzen L; Lunde M; Eriksen J; Plenge P; Mellerup ET
    Acta Psychiatr Scand; 1994 Aug; 90(2):141-4. PubMed ID: 7976461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sertraline improves symptoms in children and adolescents with major depressive disorder.
    McClure EB; Leibenluff E; Pine DS
    Evid Based Ment Health; 2004 Feb; 7(1):10. PubMed ID: 14769654
    [No Abstract]   [Full Text] [Related]  

  • 28. The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic study: Erratum.
    Ther Drug Monit; 2018 Jun; 40(3):381. PubMed ID: 29746436
    [No Abstract]   [Full Text] [Related]  

  • 29. Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry.
    Stancil SL; Tumberger J; Strawn JR
    Clin Transl Sci; 2022 Apr; 15(4):816-823. PubMed ID: 34913258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression.
    Bowman MA; Daws LC
    Front Neurosci; 2019; 13():156. PubMed ID: 30872996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.
    Perahia DG; Bangs ME; Zhang Q; Cheng Y; Ahl J; Frakes EP; Adams MJ; Martinez JM
    Drug Healthc Patient Saf; 2013; 5():211-9. PubMed ID: 24348072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trazodone effects on [H]-paroxetine and alpha(2)-adrenoreceptors in platelets of patients with major depression.
    Marazziti D; Consoli G; Golia F; Baroni S; Masala I; Carlini M; Catena Dell'osso M
    Neuropsychiatr Dis Treat; 2010 May; 6():255-9. PubMed ID: 20520789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents.
    Nobile M; Begni B; Giorda R; Frigerio A; Marino C; Molteni M; Ferrarese C; Battaglia M
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1396-402. PubMed ID: 10560226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
    Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
    J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
    Sallee FR; Hilal R; Dougherty D; Beach K; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1998 Jul; 37(7):777-84. PubMed ID: 9666634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
    Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.